Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nutex Health Inc.NUTX · Entity 4803 | Chief Operating Officer | March 11, 2026 | March 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nutex Health Inc.
Report date March 11, 2026 · Filed March 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2029-03-01 | Direct | 2,411 |
Reported balance
After 2026-03-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-11 · Exercise / conversion · Acquired 2,411 · Balance 2,411 F1: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. F2: On March 11, 2026, the Reporting Person was granted 2,411 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.
F2: On March 11, 2026, the Reporting Person was granted 2,411 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 11, 2026 Filed Mar 24, 2026 19:41 UTC | Nutex Health Inc. NUTX · Entity 4803 | Exercise / conversionRestricted Stock Units · Derivative | 2,411 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002093295-26-000001 · primary_doc.xml · derivative · entry 1 Bamburg Wesley Shane · CIK 0002093295 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,411 Underlying: Common Stock · 2,411 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. F1 · shares: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. F2 · derivative.exercise_date: On March 11, 2026, the Reporting Person was granted 2,411 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029. F2 · derivative.expiration_date: On March 11, 2026, the Reporting Person was granted 2,411 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.